CClinicalTrials.gg
CompletedNCT04668677Updated Mar 9, 2021

Return to Work and Functional Results of French Soldiers After Anterior Cruciate Ligament Reconstruction

An observational study in Anterior Cruciate Ligament Rupture, sponsored by Direction Centrale du Service de Santé des Armées. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-09.

Sponsored by Direction Centrale du Service de Santé des Armées · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
222
Ages
18 Years and older
Sex
All
01

Study summary

The return to work in the military population after surgical reconstruction of the anterior cruciate ligament (ACL) has been poorly investigated within the French armed forces. Only American studies are available and show that this surgery has a significant impact on the operational capacity of soldiers.

ACL rupture is extremely frequent in active populations. This pathology has already been extensively explored in at-risk populations, particularly in sports. Most studies show that the resumption of sport is greatly affected by this pathology.

Furthermore, an over-risk (10 times greater incidence of ACL rupture) in the military has been demonstrated.

02

Conditions studied

  • Anterior Cruciate Ligament Rupture

Browse trials for

03

In context

Rupture

557 studies on the registry are indexed under Rupture; 97 are open to participants now.

This study's enrollment of 222 is above the median of 100 across 203 observational studies indexed under Rupture.

Browse Rupture studies →

Lead sponsor

Direction Centrale du Service de Santé des Armées is the lead sponsor of 93 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will be composed of military personnel who underwent first-line ACL reconstruction surgery in a military hospital (military training hospital Bégin or military training hospital Percy) between January 2014 and May 2019.

Inclusion criteria

  • Military personnel who underwent first-line ACL reconstruction surgery between January 2014 and May 2019

Exclusion criteria

Exclusion Criteria:

  • People who have had ACL reconstruction surgery after initial failure
  • People with a multiligamentous knee condition
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
222 participants (actual)
Patient registry
No

Interventions

  • OtherOn-line questionnaire

    On-line questionnaire about working life, medical care, functional recovery, quality of life and psychological state.

06

What researchers measure

Primary outcomes

  1. Percentage of participants who regained their professional competence one year after anterior cruciate ligament (ACL) reconstruction surgery.

    Time frame: 1 year after anterior cruciate ligament (ACL) reconstruction surgery.

07

Study locations

1 site
  • Hôpital d'Instruction des Armées Percy
    Clamart, 92140, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04668677
Lead sponsor
Direction Centrale du Service de Santé des Armées
Responsible party
Sponsor
First posted
Dec 16, 2020
Start date
Dec 10, 2020
Primary completion
Jan 6, 2021
Completion
Jan 6, 2021
Last update
Mar 9, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion